Literature DB >> 10715900

Acute generalized exanthematous pustulosis associated with oral terbinafine.

A P Hall1, B Tate.   

Abstract

A case history of acute generalized exanthematous pustulosis (AGEP) following oral terbinafine is reported. A 64-year-old woman presented with a rapidly spreading micropustular eruption 3 days after completing a 28-day course of oral terbinafine. There was a positive family history of psoriasis but no personal history. The clinical presentation and histopathology were consistent with AGEP. There was nearly complete resolution of the pustular eruption within 3.5 weeks following cessation of oral terbinafine and treatment with topical and systemic corticosteroids. The patient has remained free of any recurrence 18 months later. A summary of drugs known to be associated with AGEP is presented. Prompt recognition of AGEP is stressed in order to avoid confusion with acute generalized pustular psoriasis or a systemic infection. The most important aspect of management is the immediate withdrawal of the suspect drug.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10715900     DOI: 10.1046/j.1440-0960.2000.00387.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  4 in total

1.  A 10-year-old girl with acute generalised exanthematous pustulosis.

Authors:  Wai-Ming Chan; Yat-Wah Kwan; Chi-Wai Leung
Journal:  Eur J Pediatr       Date:  2004-08-07       Impact factor: 3.860

2.  Acute Generalized Exanthematous Pustulosis Induced by Erlotinib (Tarceva) with Superimposed Staphylococcus aureus Skin Infection in a Pancreatic Cancer Patient: A Case Report.

Authors:  Egbert Liquete; Syed Ali; Revark Kammo; Moiz Ali; Fadi Alali; Hima Challa; Farid Fata
Journal:  Case Rep Oncol       Date:  2012-05-23

Review 3.  Generalized pustular psoriasis and hepatic dysfunction associated with oral terbinafine therapy.

Authors:  Byung-Soo Kim; Ho-Sun Jang; Seung-Wook Jwa; Bong-Seok Jang; Moon-Bum Kim; Chang-Keun Oh; Yoo-Wook Kwon; Kyung-Sool Kwon
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

4.  Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality.

Authors:  Boni Elewski; Amir Tavakkol
Journal:  Ther Clin Risk Manag       Date:  2005-12       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.